COVID-19 Records

Daszak CBP Package — page 13

of 23 pages

← p.12 p.14 → · this page in the original PDF · package

m k Ty pe Remark aspects of their collaboration, including related to cell phone data. Link * DASZAK and EcoHealth has been awarded a number of contracts and grants from the U.S. federal government. These include contracts with the DHS Chemical and Biological Threat Division. Many items that EcoHealth studies are likely to be subject to serious non-disclosure agreements with the U.S. government and/or be export controlled. * Much of the funding DASZAK receives is put towards gain of function research. This research involves experimentation that aims or is expected to increase the transmissibility and/or virulence of pathogens. The ultimate objective of such research is to better inform public health and preparedness efforts and/or development of medical countermeasures. Link * In 2013, DASZAK was a coauthor of publication "Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor" with Zhengli SHI and Ralph BARIC. This paper is of significance due to the first reporting of a SL-CoV-WIV1 (SARS-like coronavirus WIV1) binding to human cells and infecting them. Link * A follow up article published in Nature magazine on 12/12/2015 titled "Engineered bat virus stirs debate over risky research, Lab-made coronavirus related to SARS can infect human cells" debates "whether engineering lab variants of viruses with possible pandemic potential is worth the risks." Link Respectfully, National Targeting Security Specialist National Targeting Center (NTC) Tactical Targeting WARNING: This document is LAW ENFORCEMENT SENSITIVE and is designated for OFFICIAL USE ONLY. It contains information that may be exempt from public release under the Freedom of Information Act (5USC552). This document is to be controlled, handled, transmitted, distributed, and disposed of in accordance with DHS policy relating to FOUO information, and is not to be released to the public or personnel who do not have a valid "need-to-know" without prior approval from OFO National Targeting Center - Passenger at 571-468-1000. UNCLASSIFIED//LES UNCLASSIFIED//LES

This is our OCR of the page, with running headers and footers removed. The Committee's PDF is authoritative; quote from it. Machine-readable, including the uncleaned text: /api/page/daszak_cbp/13

Records on this page

RecordDateTypePages
Re: 2021-02-02 email 12–14